Search Results - "Vallböhmer, D."

A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer by Vallböhmer, D, Hölscher, Arnulf H, DeMeester, S, DeMeester, T, Salo, J, Peters, J, Lerut, T, Swisher, S G, Schröder, W, Bollschweiler, E, Hofstetter, W

“…To evaluate 5-year survival of patients with locally advanced esophageal cancer (LAEC) who have undergone multimodality treatment with complete histopathologic…”
Get full text

Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis by Bollschweiler, E., Metzger, R., Drebber, U., Baldus, S., Vallböhmer, D., Kocher, M., Hölscher, A. H.

“…Background: This study investigates response and prognosis after neo-adjuvant chemoradiation (CTx/RTx) in patients with advanced esophageal carcinoma,…”
Get full text

MicroRNA profiling in locally advanced esophageal cancer indicates a high potential of miR‐192 in prediction of multimodality therapy response by Odenthal, M., Bollschweiler, E., Grimminger, P.P., Schröder, W., Brabender, J., Drebber, U., Hölscher, A.H., Metzger, R., Vallböhmer, D.

“…To identify possible predictive markers, our study aimed to characterize microRNA (miRNA) profiles of responder and nonresponder in the multimodality therapy…”
Get full text

High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality? by Metzger, R., Bollschweiler, E., Vallböhmer, D., Maish, M., DeMeester, T. R., Hölscher, A. H.

“…SUMMARY  Aimed at reducing surgical deaths, several initiatives have attempted to establish volume‐based referral strategies in high risk surgery. The detailed…”
Get full text

Options in the management of esophageal perforation: analysis over a 12-year period by Vallböhmer, D., Hölscher, A. H., Hölscher, M., Bludau, M., Gutschow, C., Stippel, D., Bollschweiler, E., Schröder, W.

“…SUMMARY Controversies exist about the management of esophageal perforation in order to eliminate the septic focus. The aim of this study was to assess the…”
Get full text

Predictive and prognostic molecular markers in outcome of esophageal cancer by Vallböhmer, D., Lenz, H.-J.

“…Despite improvements in detection, surgical resection and (neo‐) adjuvant therapy, the overall survival in esophageal cancer remains lower than in other solid…”
Get full text

[18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer by Vallböhmer, D., Hölscher, A.H., Schneider, P.M., Schmidt, M., Dietlein, M., Bollschweiler, E., Baldus, S., Alakus, H., Brabender, J., Metzger, R., Mönig, S. P.

“…Background and Objectives Neoadjuvant chemotherapy is applied to improve the prognosis of patients with advanced gastric cancer. However, only a major…”
Get full text

Lymph node size and metastatic infiltration in adenocarcinoma of the pancreatic head by Prenzel, K.L, Hölscher, A.H, Vallböhmer, D, Drebber, U, Gutschow, C.A, Mönig, S.P, Stippel, D.L

“…Abstract Background Preoperative lymph node staging of pancreatic cancer by CT relies on the premise that malignant lymph nodes are larger than benign nodes…”
Get full text

Radiotherapy in elderly patients with inoperable esophageal cancer: Is there a benefit? by Semrau, R., Herzog, S.L., Vallböhmer, D., Kocher, M., Hölscher, A., Müller, R.-P.

“…Background Radiation oncologists increasingly face elderly cancer patients impaired by comorbidities and reduced performance status. As less data are available…”
Get full text

Duodenal gastrointestinal stroma tumours: difficulties of an individualized risk assessment and controversies in surgical therapy by Vallböhmer, D., Knoefel, W. T.

Get full text

Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancer by Hoffmann, A.C., Kaifi, J.T., Vallböhmer, D., Yekebas, E., Grimminger, P., Leers, J.M., Izbicki, J.R., Hölscher, A.H., Schneider, P.M., Metzger, R., Brabender, J.

“…Background and Objectives To further improve the screening, diagnosis and therapy of patients with non‐small cell lung cancer (NSCLC) additional diagnostic…”
Get full text

Vascular endothelial growth factor expression following ischemic conditioning of the gastric conduit by Bludau, M., Hölscher, A. H., Vallböhmer, D., Metzger, R., Bollschweiler, E., Schröder, W.

“…Summary The partial devascularization of the stomach, necessary for esophageal reconstruction with a gastric conduit, impairs microcirculation in the…”
Get full text

Evaluation of histological regression grading systems in the neoadjuvant therapy of rectal cancer: Do they have prognostic impact? by Vallböhmer, D., Bollschweiler, E., Brabender, J., Wedemeyer, I., Grimminger, P. P., Metzger, R., Schröder, W., Gutschow, C., Hölscher, A. H., Drebber, U.

“…Purpose Neoadjuvant treatment options have been developed to improve survival of patients with locally advanced rectal cancer. As only patients with a major…”
Get full text

GNAS1 T393C polymorphism is associated with histopathological response to neoadjuvant radiochemotherapy in esophageal cancer by Alakus, H, Warnecke-Eberz, U, Bollschweiler, E, Mönig, S P, Vallböhmer, D, Brabender, J, Drebber, U, Baldus, S E, Riemann, K, Siffert, W, Hölscher, A H, Metzger, R

“…Recent studies have shown an association between the GNAS1 T393C polymorphism and clinical outcome for various solid tumors. In this study, we genotyped 51…”
Get full text

Survivin expression in gastric cancer: Association with histomorphological response to neoadjuvant therapy and prognosis by Vallböhmer, D., Drebber, U., Schneider, P.M., Baldus, S., Bollschweiler, E., Brabender, J., Warnecke-Eberz, U., Mönig, S., Hölscher, A.H., Metzger, R.

“…Background and Objectives Neoadjuvant therapy is applied to improve the prognosis associated with advanced gastric cancer. Only patients with a major response…”
Get full text

Prognostic factors in definitive radiochemotherapy of advanced inoperable esophageal cancer by Semrau, R., Herzog, S. L., Vallböhmer, D., Kocher, M., Hölscher, A. H., Müller, R.-P.

“…SUMMARY The aim of this study was to assess the efficacy and prognostic factors of definitive radiochemotherapy (RCT) for inoperable esophageal cancer. Between…”
Get full text

Thoracoscopic enucleation of esophageal leiomyomas: a feasible and safe procedure by Vallböhmer, D, Hölscher, A H, Brabender, J, Bollschweiler, E, Gutschow, C

“…In recent years, minimally invasive approaches have been introduced, providing thoracoscopic/laparoscopic techniques in the treatment of esophageal leiomyomas…”
Get more information

Reflux esophagitis, high-grade neoplasia, and early Barrett’s carcinoma—what is the place of the Merendino procedure? by Hölscher, A. H., Vallböhmer, D., Gutschow, C., Bollschweiler, E.

“…Introduction Because of the increasing frequency of Barrett’s cancer in Western industrialized countries, the management of reflux disease with the potential…”
Get full text

Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus by Vallböhmer, D., DeMeester, S. R., Peters, J. H., Oh, D. S., Kuramochi, H., Shimizu, D., Hagen, J. A., Danenberg, K. D., Danenberg, P. V., DeMeester, T. R., Chandrasoma, P. T.

“…The molecular pathogenesis of Barrett's esophagus is poorly understood. Evidence suggests that at a phenotypic level, the metaplastic process begins with the…”
Get full text

The Resection of the Azygos Vein — Necessary or Redundant Extension of Transthoracic Esophagectomy? by Schröder, W., Vallböhmer, D., Bludau, M., Banczyk, A., Gutschow, C., Hölscher, A. H.

“…Due to the increasing use of minimally invasive techniques, some authors have questioned the necessity to dissect the azygos vein as part of the en-bloc…”
Get full text